Literature DB >> 28949052

Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction.

Emil Wolsk1, David Kaye2, Barry A Borlaug3, Daniel Burkhoff4, Dalane W Kitzman5, Jan Komtebedde6, Carolyn S P Lam7, Piotr Ponikowski8, Sanjiv J Shah9, Finn Gustafsson1.   

Abstract

AIMS: Patients with heart failure and preserved ejection fraction (HFpEF) are characterized by functional impairment and an abnormal haemodynamic response to exercise. The six-minute walk test (6MWT) serves as a standardized test for functional capacity quantification in heart failure patients, and is associated with cardiovascular outcomes. However, as the association between 6MWT and haemodynamic parameters during rest and exercise in HFpEF patients is unknown, we sought to elucidate this relationship. METHODS AND
RESULTS: Overall, 64 patients enrolled in the REDUCE LAP-HF trial completed a 6MWT at baseline. Univariate and multivariable linear regression models were used to assess the associations between 6MWT and measured or derived haemodynamic variables at baseline, during light/moderate exercise (20 W), and at peak supine exercise. The average 6MWT distance was 318 ± 106 m. At rest, in a multivariable model, only pulmonary capillary wedge pressure (PCWP) was significantly associated with 6MWT [coefficient: -5.4, 95% confidence interval (CI) -10.4, -0.5, P = 0.033]. During light/moderate exercise, mean pulmonary artery pressure was associated with 6MWT in a multivariable model (coefficient: -3.5, 95% CI -6.8, -0.3, P = 0.033). During peak exercise, central venous pressure, cardiac index (CI), and PCWP/CI correlated with 6MWT; however, workload corrected PCWP was the only variable independently associated with 6MWT (coefficient: -0.8, 95% CI -1.3, -0.4, P < 0.001). The variance in 6MWT was modestly explained by measured or derived haemodynamic variables at rest or at any stage of exercise (r2  = 7-17%).
CONCLUSION: Workload corrected PCWP correlated best with 6MWT performance in HFpEF patients. Baseline haemodynamic variables were modestly correlated with 6MWT, suggesting that 6MWT performance in HFpEF patients may be significantly influenced by extra-cardiac factors.
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.

Entities:  

Keywords:  Exercise; Haemodynamics; Heart failure with preserved ejection fraction; REDUCE LAP-HF; Six-minute walk test

Mesh:

Year:  2017        PMID: 28949052     DOI: 10.1002/ejhf.976

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  16 in total

Review 1.  Diastolic Stress Testing Along the Heart Failure Continuum.

Authors:  T Jake Samuel; Rhys Beaudry; Satyam Sarma; Vlad Zaha; Mark J Haykowsky; Michael D Nelson
Journal:  Curr Heart Fail Rep       Date:  2018-12

2.  Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Janet D Pierce; Qiuhua Shen; Diane E Mahoney; Faith Rahman; Kathryn J Krueger; Francisco J Diaz; Lauren Clark; Carol Smith; James Vacek; John B Hiebert
Journal:  Am J Cardiol       Date:  2022-05-27       Impact factor: 3.133

3.  Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.

Authors:  Barry A Borlaug; John Blair; Martin W Bergmann; Heiko Bugger; Dan Burkhoff; Leonhard Bruch; David S Celermajer; Brian Claggett; John G F Cleland; Donald E Cutlip; Ira Dauber; Jean-Christophe Eicher; Qi Gao; Thomas M Gorter; Finn Gustafsson; Chris Hayward; Jan van der Heyden; Gerd Hasenfuß; Scott L Hummel; David M Kaye; Jan Komtebedde; Joseph M Massaro; Jeremy A Mazurek; Scott McKenzie; Shamir R Mehta; Mark C Petrie; Marco C Post; Ajith Nair; Andreas Rieth; Frank E Silvestry; Scott D Solomon; Jean-Noël Trochu; Dirk J Van Veldhuisen; Ralf Westenfeld; Martin B Leon; Sanjiv J Shah
Journal:  Circulation       Date:  2022-03-31       Impact factor: 39.918

Review 4.  Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction: Quantification of Multiorgan System Reserve Capacity.

Authors:  Matthew Nayor; Nicholas E Houstis; Mayooran Namasivayam; Jennifer Rouvina; Charles Hardin; Ravi V Shah; Jennifer E Ho; Rajeev Malhotra; Gregory D Lewis
Journal:  JACC Heart Fail       Date:  2020-06-10       Impact factor: 12.035

Review 5.  Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Mahnoor Mir; Robert Chilton
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 6.  Device-based treatment options for heart failure with preserved ejection fraction.

Authors:  Chihiro Miyagi; Takuma Miyamoto; Jamshid H Karimov; Randall C Starling; Kiyotaka Fukamachi
Journal:  Heart Fail Rev       Date:  2021-01-12       Impact factor: 4.214

7.  Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.

Authors:  David M Kaye; Mark C Petrie; Scott McKenzie; Gerd Hasenfuβ; Filip Malek; Martijn Post; Robert N Doughty; Jean-Noël Trochu; Finn Gustafsson; Irene Lang; Adam Kolodziej; Ralf Westenfeld; Martin Penicka; Mark Rosenberg; Jörg Hausleiter; Philip Raake; Guillaume Jondeau; Martin W Bergmann; Tim Spelman; Huseyin Aytug; Piotr Ponikowski; Chris Hayward
Journal:  ESC Heart Fail       Date:  2018-10-11

8.  Clinically Important Differences for Mobility Measures Derived from the Testosterone Trials.

Authors:  Alisa J Stephens-Shields; John T Farrar; Susan S Ellenberg; Thomas W Storer; Thomas M Gill; Shehzad Basaria; Marco Pahor; Jane A Cauley; Kristine E Ensrud; Peter Preston; David Cella; Peter J Snyder; Shalender Bhasin
Journal:  J Am Geriatr Soc       Date:  2020-11-18       Impact factor: 5.562

9.  Haemodynamic changes of interatrial shunting devices for heart failure: a systematic review and meta-analysis.

Authors:  Tieci Yi; Min Li; Fangfang Fan; Lin Qiu; Zhi Wang; Haoyu Weng; Xiaoke Shang; Changdong Zhang; Wei Ma; Yan Zhang; Yong Huo
Journal:  ESC Heart Fail       Date:  2022-03-23

Review 10.  Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction.

Authors:  David M Kaye; Shane Nanayakkara
Journal:  Front Cardiovasc Med       Date:  2019-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.